Strategic investors are worth it when they shorten your path to a customer or a regulator, not when they merely validate you. H2SITE's record — a Series B with Engie Ventures, Breakthrough Energy Ventures, the EIC Fund and Hy24 — shows the pattern for capital-intensive companies: money that arrives attached to industrial channels. The trade is information rights and perceived alignment, so structure the terms before the cheque.
Key takeaways
- Take strategic money when the investor shortens a real bottleneck — a customer, a site, a regulatory path — not for validation.
- The main cost is optionality: a corporate on the cap table can cool interest from that corporate competitors.
- Negotiate information rights, no right of first refusal, and no exclusivity before signing, not at exit.
- Blended rounds work best: a financial lead sets price and governance, strategics take minority allocations.
- In deep tech and energy, public and quasi-public funds often de-risk a round for private capital rather than compete with it.
Founders in capital-intensive sectors get a version of the same offer eventually: a corporate venture arm, or an energy major's fund, wants to lead or join the round. The money is real, the logo helps, and the risks are almost never discussed in the first meeting.
Rather than talking about strategic capital in the abstract, this walks through the decision using a documented record: Andrés Galnares, CEO and co-founder of H2SITE (Loiu, Biscay, Spain), which builds hydrogen separation and onsite production technology.
| | | |---|---| | Founder | Andrés Galnares | | Company | H2SITE (Loiu, Spain) | | Category | Hydrogen / deep tech | | Total raised | roughly $50M | | Latest round | Series B — roughly $46M | | Round date | June 2026 | | Named backers on record | Engie Ventures, Breakthrough Energy Ventures, EIC Fund, Hy24 |
Read the backer list as a structure rather than a list of names. There is an industrial operator's fund (Engie Ventures), a climate-specialist fund (Breakthrough Energy Ventures), a public instrument (the EU's EIC Fund) and a sector-dedicated infrastructure investor (Hy24). Four different underwriting logics, one round.
The industrial fund is buying an option on deployment. Its return matters, but the strategic thesis is access — to the technology, to the roadmap, and often to a first look at supply.
The thematic fund is buying category exposure and can tolerate the timeline that pure financial funds cannot.
The public instrument is buying de-risking of a national or regional priority, which is why it usually arrives with reporting obligations and slower process, and why it makes the private money in the round easier to close.
The infrastructure investor is buying the project layer, not the software layer, and will care about bankability of installations more than about ARR.
Knowing which logic you are talking to changes what you show in the meeting.
One question decides it: does this investor remove a specific bottleneck you cannot remove yourself?
Legitimate bottlenecks include a pilot site you cannot otherwise access, a certification path, an offtake agreement, a distribution channel with a two-year sales cycle. Validation is not a bottleneck. If the answer is "it signals credibility to the market," you are paying for a logo with equity and optionality.
The hidden price of strategic capital is who stops talking to you. If your buyer market has three serious acquirers and one of them sits on your cap table with information rights, the other two now see a competitor's investee. In consolidated markets this can quietly decide your exit before you have started the process.
No right of first refusal and no matching rights on an acquisition.
Information rights limited to standard financial reporting, not product roadmap or pipeline.
Board observer at most, unless the cheque is genuinely lead-sized.
The cleanest version is a blended round: a financial lead sets the price and the governance, and strategic investors take minority allocations alongside. This keeps the valuation defensible in your next round and keeps the strategic relationship commercial rather than structural.
The figures here come from structured funding records: total raised, round stage, round size, round date, and named participants. They do not include the terms of the round, governance rights, or any commercial agreements between the company and its investors. The presence of an industrial fund does not by itself imply a commercial arrangement.
List your top three bottlenecks for the next 18 months. If a strategic investor removes one of them in a way you can describe in a sentence, take the money and negotiate the terms above. If they remove none of them, take the financial round — it is cheaper than it looks.
Frequently asked questions
- Should I take money from a corporate venture arm?
- Take it when the corporate can shorten a real bottleneck — a pilot site, a distribution channel, a regulatory relationship — and when the terms do not restrict who else can buy from you or invest in you later. Take it for validation alone and you pay in optionality.
- What terms should I avoid with a strategic investor?
- Right of first refusal on an acquisition, exclusivity in a territory or channel, board seats disproportionate to ownership, and broad information rights that expose your roadmap to a potential competitor. Cap information rights to standard financial reporting.
- Will a corporate on my cap table scare off their competitors?
- Sometimes, and this is the main hidden cost. Assess how consolidated your buyer market is. In a market with three plausible acquirers, one on your cap table can remove the other two from your future process.
- How do public or quasi-public funds fit in?
- In capital-intensive sectors such as hydrogen, public instruments frequently anchor rounds and lower the risk profile for private investors. They are typically slower and more documentation-heavy, so start the process earlier than you would with a fund.
- Where do the figures in this article come from?
- From the structured founder funding records we maintain: total raised, round stage, round amount, round date, and named participants. They do not include deal terms or governance provisions.
